City-Wide Behavioural Neurology Rounds - P. Verhoeff: An update on some recent pharmacological RCTs for Alzheimer's Disease

Download or view the Presentation Flyer in PDF here.

Presenter:

Paul Verhoeff MD, PhD, FRCPC

8:00am - 8:45am: Presentation
8:45am - 9:00am: Interactive session

Location:

Baycrest Hospital
Ben and Hilda Katz Building
2nd floor
Classrooms ABC

Learning Objectives:

• To review the evidence from RCTs supporting the efficacy and safety of more novel cognitive enhancers in Alzheimer’s disease, including β-amyloid immunization, tau aggregation inhibitors, mitochondrial membrane stabilizers, Gingko biloba, and multi-nutrients improving synapse formation.
• To discuss how these may affect the pathophysiology of Alzheimer’s disease and how these approaches could lead to future medications affecting not only the symptoms but also the course of Alzheimer’s disease.

This event will be videoconferenced from Baycrest to the following participating sites:

• Sunnybrook Health Sciences Centre Room A450
• Toronto Rehabilitation Institute
• St. Michael’s Hospital
• Bridgepoint Health
• Bloorview Kids Rehab

This event is an accredited group learning activity as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada.

We gratefully acknowledge educational grants from Lundbeck Canada Inc., Novartis Inc., and Pfizer Canada which support these rounds

• Rounds are Restricted to Health Care Professionals